Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-16

Clinical Trial Update: Effect of Oxcarbazepine on Serum Brain Derived Neurotrophic Factor (BDNF) in Bipolar Disorder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the effect of oxcarbazepine on serum brain-derived neurotrophic factor (BDNF) in bipolar disorder has completed with posted res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxcarbazepine (Oxcarbazepine)

Snippet

Sponsor: All India Institute of Medical Sciences, Bhubaneswar | Conditions: Bipolar Disorder | Phase 4 | Status: COMPLETED | Results posted: 2019-04-16